Cargando…

Biological activity of oxadiazole and thiadiazole derivatives

ABSTRACT: The 5-membered oxadiazole and thiadiazole scaffolds are the most privileged and well-known heterocycles, being a common and essential feature of a variety of natural products and medicinal agents. These scaffolds take up the center position and are the core structural components of numerou...

Descripción completa

Detalles Bibliográficos
Autores principales: Atmaram, Upare Abhay, Roopan, Selvaraj Mohana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9106569/
https://www.ncbi.nlm.nih.gov/pubmed/35562490
http://dx.doi.org/10.1007/s00253-022-11969-0
_version_ 1784708318036492288
author Atmaram, Upare Abhay
Roopan, Selvaraj Mohana
author_facet Atmaram, Upare Abhay
Roopan, Selvaraj Mohana
author_sort Atmaram, Upare Abhay
collection PubMed
description ABSTRACT: The 5-membered oxadiazole and thiadiazole scaffolds are the most privileged and well-known heterocycles, being a common and essential feature of a variety of natural products and medicinal agents. These scaffolds take up the center position and are the core structural components of numerous drugs that belong to different categories. These include antimicrobial, anti-tubercular, anti-inflammatory, analgesic, antiepileptic, antiviral, and anticancer agents. In this review, we mostly talk about the isomers 1,2,4-oxadiazole and 1,3,4-thiadiazole because they have important pharmacological properties. This is partly because they are chemical and heat resistant, unlike other isomers, and they can be used as bio-isosteric replacements in drug design. We are reviewing the structural modifications of different oxadiazole and thiadiazole derivatives, more specifically, the anti-tubercular and anticancer pharmacological activities reported over the last 5 years, as we have undertaken this as a core area of research. This review article desires to do a thorough study and analysis of the recent progress made in the important biological isomers 1,2,4-oxadiazole and 1,3,4-thiadiazol. This will be a great place to start for future research. KEY POINTS: • Five-membered heterocyclic compound chemistry and biological activity recent survey. • Synthesis and pharmacological evolution of 1,2,4-oxadiazole and 1,3,4-thiadiazole are discussed in detail. • The value and significance of heterocyclic compounds in the field of drug designing are highlighted. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00253-022-11969-0.
format Online
Article
Text
id pubmed-9106569
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-91065692022-05-16 Biological activity of oxadiazole and thiadiazole derivatives Atmaram, Upare Abhay Roopan, Selvaraj Mohana Appl Microbiol Biotechnol Mini-Review ABSTRACT: The 5-membered oxadiazole and thiadiazole scaffolds are the most privileged and well-known heterocycles, being a common and essential feature of a variety of natural products and medicinal agents. These scaffolds take up the center position and are the core structural components of numerous drugs that belong to different categories. These include antimicrobial, anti-tubercular, anti-inflammatory, analgesic, antiepileptic, antiviral, and anticancer agents. In this review, we mostly talk about the isomers 1,2,4-oxadiazole and 1,3,4-thiadiazole because they have important pharmacological properties. This is partly because they are chemical and heat resistant, unlike other isomers, and they can be used as bio-isosteric replacements in drug design. We are reviewing the structural modifications of different oxadiazole and thiadiazole derivatives, more specifically, the anti-tubercular and anticancer pharmacological activities reported over the last 5 years, as we have undertaken this as a core area of research. This review article desires to do a thorough study and analysis of the recent progress made in the important biological isomers 1,2,4-oxadiazole and 1,3,4-thiadiazol. This will be a great place to start for future research. KEY POINTS: • Five-membered heterocyclic compound chemistry and biological activity recent survey. • Synthesis and pharmacological evolution of 1,2,4-oxadiazole and 1,3,4-thiadiazole are discussed in detail. • The value and significance of heterocyclic compounds in the field of drug designing are highlighted. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00253-022-11969-0. Springer Berlin Heidelberg 2022-05-14 2022 /pmc/articles/PMC9106569/ /pubmed/35562490 http://dx.doi.org/10.1007/s00253-022-11969-0 Text en © The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Mini-Review
Atmaram, Upare Abhay
Roopan, Selvaraj Mohana
Biological activity of oxadiazole and thiadiazole derivatives
title Biological activity of oxadiazole and thiadiazole derivatives
title_full Biological activity of oxadiazole and thiadiazole derivatives
title_fullStr Biological activity of oxadiazole and thiadiazole derivatives
title_full_unstemmed Biological activity of oxadiazole and thiadiazole derivatives
title_short Biological activity of oxadiazole and thiadiazole derivatives
title_sort biological activity of oxadiazole and thiadiazole derivatives
topic Mini-Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9106569/
https://www.ncbi.nlm.nih.gov/pubmed/35562490
http://dx.doi.org/10.1007/s00253-022-11969-0
work_keys_str_mv AT atmaramupareabhay biologicalactivityofoxadiazoleandthiadiazolederivatives
AT roopanselvarajmohana biologicalactivityofoxadiazoleandthiadiazolederivatives